{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T01:24:13Z","timestamp":1787275453901,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"DOI":"10.1038\/s41401-026-01900-y","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T01:00:17Z","timestamp":1787274017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RNF6 activates the AKT\/mTOR signaling pathway by inhibiting PTEN via K27-linked polyubiquitination in myeloma"],"prefix":"10.1038","author":[{"given":"Yue-ya","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-huan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-fu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-li","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-liang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"1900_CR1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/ajh.25791","volume":"95","author":"SV Rajkumar","year":"2020","unstructured":"Rajkumar SV. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020;95:548\u201367.","journal-title":"Am J Hematol"},{"key":"1900_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.146","volume":"3","author":"P Yang","year":"2022","unstructured":"Yang P, Qu Y, Wang M, Chu B, Chen W, Zheng Y, et al. Pathogenesis and treatment of multiple myeloma. MedComm. 2022;3:e146.","journal-title":"MedComm"},{"key":"1900_CR3","doi-asserted-by":"crossref","unstructured":"Fusco N, Sajjadi E, Venetis K, Gaudioso G, Lopez G, Corti C et al. PTEN alterations and their role in cancer management: are we making headway on precision medicine? Genes. 2020;11:719.","DOI":"10.3390\/genes11070719"},{"key":"1900_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1868-7083-6-16","volume":"6","author":"G Piras","year":"2014","unstructured":"Piras G, Monne M, Palmas AD, Calvisi A, Asproni R, Vacca F, et al. Methylation analysis of the phosphates and tensin homologue on chromosome 10 gene (PTEN) in multiple myeloma. Clin Epigenetics. 2014;6:16.","journal-title":"Clin Epigenetics"},{"key":"1900_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/or.2024.1430237","volume":"18","author":"X Li","year":"2024","unstructured":"Li X, Yang P, Hou X, Ji S. Post-translational modification of PTEN protein: quantity and activity. Oncol Rev. 2024;18:1430237.","journal-title":"Oncol Rev"},{"key":"1900_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cell.2006.11.040","volume":"128","author":"LC Trotman","year":"2007","unstructured":"Trotman LC, Wang X, Alimonti A, Chen Z, Teruya-Feldstein J, Yang H, et al. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell. 2007;128:141\u201356.","journal-title":"Cell"},{"key":"1900_CR7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41401-021-00662-z","volume":"43","author":"YM He","year":"2022","unstructured":"He YM, Zhou XM, Jiang SY, Zhang ZB, Cao BY, Liu JB, et al. TRIM25 activates AKT\/mTOR by inhibiting PTEN via K63-linked polyubiquitination in non-small cell lung cancer. Acta Pharmacol Sin. 2022;43:681\u201391.","journal-title":"Acta Pharmacol Sin"},{"key":"1900_CR8","doi-asserted-by":"crossref","unstructured":"Lee YR, Chen M, Lee JD, Zhang J, Lin SY, Fu TM et al. Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway. Science. 2019;364:651.","DOI":"10.1126\/science.aau0159"},{"key":"1900_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188723","volume":"1877","author":"K Wang","year":"2022","unstructured":"Wang K, Liu J, Li YL, Li JP, Zhang R. Ubiquitination\/de-ubiquitination: a promising therapeutic target for PTEN reactivation in cancer. Biochim Biophys Acta Rev Cancer. 2022;1877:188723.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1900_CR10","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41401-019-0309-6","volume":"41","author":"Y Ren","year":"2020","unstructured":"Ren Y, Xu X, Mao CY, Han KK, Xu YJ, Cao BY, et al. RNF6 promotes myeloma cell proliferation and survival by inducing glucocorticoid receptor polyubiquitination. Acta Pharmacol Sin. 2020;41:394\u2013403.","journal-title":"Acta Pharmacol Sin"},{"key":"1900_CR11","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1158\/1541-7786.MCR-24-0703","volume":"23","author":"Y Sun","year":"2025","unstructured":"Sun Y, Jiang L, Zhang Z, Zhu R, Liang J, Liu Z, et al. RNF6 inhibits lung adenocarcinoma cell proliferation by promoting cyclin D2 degradation. Mol Cancer Res. 2025;23:426\u201337.","journal-title":"Mol Cancer Res"},{"key":"1900_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.gendis.2023.04.004","volume":"11","author":"H Zhang","year":"2024","unstructured":"Zhang H, Zhong Y, He Y, Xu Y, Ren Y, Zhuang H, et al. RNF6 promotes chronic myelogenous leukemia cell proliferation and migration by stabilizing vimentin via multiple atypical ubiquitinations. Genes Dis. 2024;11:87\u201390.","journal-title":"Genes Dis"},{"key":"1900_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ccr.2009.02.021","volume":"15","author":"K Xu","year":"2009","unstructured":"Xu K, Shimelis H, Linn DE, Jiang R, Yang X, Sun F, et al. Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination. Cancer Cell. 2009;15:270\u201382.","journal-title":"Cancer Cell"},{"key":"1900_CR14","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3389\/fphar.2018.00673","volume":"9","author":"Q Lu","year":"2018","unstructured":"Lu Q, He Y, Wang Y, Gao L, Zheng Y, Zhang Z, et al. Saponins from Paris forrestii (Takht.) H. Li displays potent activity against acute myeloid leukemia by suppressing the RNF6\/AKT\/mTOR signaling pathway. Front Pharmacol. 2018;9:673.","journal-title":"Front Pharmacol"},{"key":"1900_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102314","volume":"298","author":"H Zhuang","year":"2022","unstructured":"Zhuang H, Ren Y, Mao C, Zhong Y, Zhang Z, Cao B, et al. Induction of zinc finger protein RNF6 auto-ubiquitination for the treatment of myeloma and chronic myeloid leukemia. J Biol Chem. 2022;298:102314.","journal-title":"J Biol Chem"},{"key":"1900_CR16","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1080\/10428194.2017.1421760","volume":"59","author":"V Ramakrishnan","year":"2018","unstructured":"Ramakrishnan V, Kumar S. PI3K\/AKT\/mTOR pathway in multiple myeloma: from basic biology to clinical promise. Leuk Lymphoma. 2018;59:2524\u201334.","journal-title":"Leuk Lymphoma"},{"key":"1900_CR17","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/onc.2011.324","volume":"31","author":"JR Molina","year":"2012","unstructured":"Molina JR, Agarwal NK, Morales FC, Hayashi Y, Aldape KD, Cote G, et al. PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma. Oncogene. 2012;31:1264\u201374.","journal-title":"Oncogene"},{"key":"1900_CR18","doi-asserted-by":"publisher","first-page":"e9910","DOI":"10.1371\/journal.pone.0009910","volume":"5","author":"Z Ding","year":"2010","unstructured":"Ding Z, Liang J, Li J, Lu Y, Ariyaratna V, Lu Z, et al. Physical association of PDK1 with AKT1 is sufficient for pathway activation independent of membrane localization and phosphatidylinositol 3 kinase. PLoS One. 2010;5:e9910.","journal-title":"PLoS One"},{"key":"1900_CR19","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1038\/s12276-022-00887-w","volume":"54","author":"A Christine","year":"2022","unstructured":"Christine A, Park MK, Song SJ, Song MS. The equilibrium of tumor suppression: DUBs as active regulators of PTEN. Exp Mol Med. 2022;54:1814\u201321.","journal-title":"Exp Mol Med"},{"key":"1900_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101088","volume":"297","author":"Y He","year":"2021","unstructured":"He Y, Jiang S, Mao C, Zheng H, Cao B, Zhang Z, et al. The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation. J Biol Chem. 2021;297:101088.","journal-title":"J Biol Chem"},{"key":"1900_CR21","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.molcel.2019.08.006","volume":"76","author":"X Qian","year":"2019","unstructured":"Qian X, Li X, Shi Z, Xia Y, Cai Q, Xu D, et al. PTEN suppresses glycolysis by dephosphorylating and inhibiting autophosphorylated PGK1. Mol Cell. 2019;76:516\u2013527.e517.","journal-title":"Mol Cell"},{"key":"1900_CR22","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1182\/bloodadvances.2022007383","volume":"7","author":"TA Bloedjes","year":"2023","unstructured":"Bloedjes TA, de Wilde G, Khan GH, Ashby TC, Shaughnessy JD, Zhan F, et al. AKT supports the metabolic fitness of multiple myeloma cells by restricting FOXO activity. Blood Adv. 2023;7:1697\u2013712.","journal-title":"Blood Adv"},{"key":"1900_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.822726","volume":"13","author":"J Zhai","year":"2022","unstructured":"Zhai J, Dong X, Yan F, Guo H, Yang J. Oleandrin: a systematic review of its natural sources, structural properties, detection methods, pharmacokinetics and toxicology. Front Pharmacol. 2022;13:822726.","journal-title":"Front Pharmacol"},{"key":"1900_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.116850","volume":"236","author":"P Garg","year":"2025","unstructured":"Garg P, Ramisetty S, Nair M, Kulkarni P, Horne D, Salgia R, et al. Strategic advancements in targeting the PI3K\/AKT\/mTOR pathway for breast cancer therapy. Biochem Pharmacol. 2025;236:116850.","journal-title":"Biochem Pharmacol"},{"key":"1900_CR25","doi-asserted-by":"crossref","unstructured":"Chakraborty S, Karmakar S, Basu M, Kal S, Ghosh MK. The E3 ubiquitin ligase CHIP drives monoubiquitylation-mediated nuclear import of the tumor suppressor PTEN. J Cell Sci. 2023;136:jcs260950.","DOI":"10.1242\/jcs.260950"},{"key":"1900_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cell.2006.11.039","volume":"128","author":"X Wang","year":"2007","unstructured":"Wang X, Trotman LC, Koppie T, Alimonti A, Chen Z, Gao Z, et al. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell. 2007;128:129\u201339.","journal-title":"Cell"},{"key":"1900_CR27","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/ncb2874","volume":"15","author":"J Zhang","year":"2013","unstructured":"Zhang J, Zhang P, Wei Y, Piao HL, Wang W, Maddika S, et al. Deubiquitylation and stabilization of PTEN by USP13. Nat Cell Biol. 2013;15:1486\u201394.","journal-title":"Nat Cell Biol"},{"key":"1900_CR28","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/ncb3218","volume":"17","author":"L Yuan","year":"2015","unstructured":"Yuan L, Lv Y, Li H, Gao H, Song S, Zhang Y, et al. Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis. Nat Cell Biol. 2015;17:1169\u201381.","journal-title":"Nat Cell Biol"},{"key":"1900_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1509","volume":"13","author":"Y He","year":"2023","unstructured":"He Y, Jiang S, Zhong Y, Wang X, Cui Y, Liang J, et al. USP7 promotes non-small-cell lung cancer cell glycolysis and survival by stabilizing and activating c-Abl. Clin Transl Med. 2023;13:e1509.","journal-title":"Clin Transl Med"},{"key":"1900_CR30","first-page":"2025","volume":"11","author":"Y Qiu","year":"2021","unstructured":"Qiu Y, Zhu H, Xu D, Feng Q, Wen C, Du Y, et al. RING-finger protein 6 enhances c-Myc-mediated Warburg effect by promoting MAD1 degradation to facilitate pancreatic cancer metastasis. Am J Cancer Res. 2021;11:2025\u201343.","journal-title":"Am J Cancer Res"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01900-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01900-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01900-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T01:00:19Z","timestamp":1787274019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01900-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":30,"alternative-id":["1900"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01900-y","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}